Your session is about to expire
← Back to Search
tACS for Depression in Lupus
Study Summary
This trial will help researchers understand if tACS can help relieve depression in patients with SLE, which may help improve their quality of life.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a low risk of attempting suicide.You have been diagnosed with drug or alcohol abuse in the past month, drug or alcohol dependence in the past 6 months, bipolar disorder, or a psychotic disorder.You have a history of certain brain-related conditions like seizures, dementia, stroke, Parkinson's disease, multiple sclerosis, or brain injury. You also have frequent or severe migraines in the past month.You have been diagnosed with systemic lupus erythematosus (SLE).You have taken high doses of intravenous glucocorticoids in the past month or are currently using benzodiazepines or anti-epileptic drugs.You have been diagnosed with a drug-induced lupus or any other rheumatologic or autoimmune disease, except for Sjogren's syndrome and mixed connective tissue disease.You have a serious medical condition (such as heart disease, AIDS, liver or kidney problems, or cancer within the past 5 years) or are receiving treatment for such a condition that may affect your ability to take part in the study.
- Group 1: Alpha-tACS
- Group 2: Theta-tACS
- Group 3: Sham Stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the number of individuals participating in this investigation?
"That is correct. According to clinicaltrials.gov, this medical research began on January 1st 2019 and was last updated in March 2022. Presently, 72 individuals are being sought out at a single facility for participation in the trial."
Is there eligibility criteria for me to join this clinical trial?
"Eligible enrollees for this clinical research must suffer from depression and have a birthdate between 18 and 65. The targeted size of the study is 72 participants."
Are there any vacant enrolment spots available in this research protocol?
"Indeed, clinicaltrials.gov shows that this investigation is actively recruiting participants as of now. This research was first posted on January 1st 2019 with the latest edits occurring in March 7th 2022. The trial necessitates 72 patients to be enrolled from one location."
Are individuals aged above 30 permitted to participate in the experiment?
"The requirements for this clinical trial stipulate that only applicants between the age of 18 and 65 can qualify. Furthermore, there are 234 trials targeting those younger than 18 years old and 1,601 studies addressing older patients above the age of 65."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger